NRXS
Neuraxis, INC
NASDAQ · Healthcare · Biotechnology · US
$7.61
−0.26%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$7.66
From 52W high−13.62%
Volume173939.00
Market cap$95.56M
P/E (TTM)—
P/S (TTM)18.0x
Div yield—
Key dataSep 18, 2026
Open
$7.66
From 52W high
−13.62%
Volume
173939.00
Market cap
$95.56M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−11.7x
P/E (TTM)
—
RSI (14)
70.9
MomentumView details →
1D Return
−0.26%
YTD Return
+64.76%
SummaryUpdated Jun 1, 2026
NeurAxis, Inc. (NASDAQ:NRXS) is a specialized medical device company founded in 2011 and headquartered in Carmel, Indiana. Originally incorporated as Innovative Health Solutions, Inc., the company rebranded to NeurAxis in March 2022 and went public in August 2023. NeurAxis focuses on developing and commercializing neuromodulation therapy devices, primarily targeting pediatric gastrointestinal disorders through its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology.
Similar companies
Latest newsMore news →
NeurAxis announced that a major national health insurer issued a new medical policy covering its PENFS neuromodulation therapy, expanding access to over 18 million additional covered lives.4d agoNeuraxis, Inc. granted restricted stock units to executives Brian Carrico, Adrian Miranda, and Thomas Carrico on July 24, 2026, as part of their compensation packages.33d ago